In order to extend these studies to a more clinically relevant system, we, therefore, isolated RNA from paired bone marrow samples taken from four individual AML patients at diagnosis and at relapse and analyzed the mRNA expression levels of a selection of signaling and target genes of the TGF-β/activin pathway (Figure 5B). This evidence concerns the gene TGFB1 and acute myeloid leukemia.